Introduction
============

Oral squamous cell carcinoma (OSCC), the most common head and neck cancer, is associated with high mortality ([@R13]). More than 170 000 individuals are diagnosed with OSCC every year worldwide ([@R33]). OSCC usually shows oral premalignant lesions (OPLs), which frequently progress from mild-to-severe dysplasia, and ultimately to invasive cancer. Oral leukoplakia, considered the most common OPLs, often transforms into OSCC with a canceration rate ranging widely from 0.13 to 36.4% according to different definitions and follow-up durations ([@R2]); in cases with severe dysplasia, a rate of up to 43% was reported ([@R28]). Therefore, early diagnosis and intervention for high-risk lesions can help prevent the occurrence of OSCC. Oral epithelial dysplasia (OED) is a warning sign for malignant transformation. However, there are no objective and noninvasive methods to typify OED. The disease progression involves an accumulation of genetic changes. Detecting aberrant genes is beneficial for the identification and elimination of OPLs, as well as the prevention of malignant transformation. Therefore, there is a need to explore the molecular pathogenesis of OPLs to detect biomarkers that can help identify lesions at high risk of developing OSCC as predictive factors to tailor clinical decisions for individual patients.

Loss of heterozygosity at the chromosome 9p21 region is frequently observed in both OPLs and head and neck squamous cell carcinoma, whereas inactivation of *p16* (*INK4a*) was described in OPL biopsies ([@R32]). [@R1] reported a significant association of *MDM2/p53* coexpression with OPLs. Recently, the focus on noncoding RNA (ncRNA) expression has outweighed the emphasis on protein-coding genes. MicroRNAs (miRNA), a group of small noncoding RNA molecules measuring 21--23 nucleotides in length, regulate the expression of almost one-third of the human genome, and play important roles in tumorigenesis ([@R3]). [@R4] found that a pri-miRNA single nucleotide polymorphism in mir26a-1 significantly alters the risk of OPL. Long noncoding RNAs (lncRNAs) constitute a novel class of long noncoding RNA molecules measuring 200 nucleotide to more than 100 kb ([@R6]). They serve as host genes for miRNAs, mediators of mRNA decay, and regulators of chromatin remodeling ([@R11]; [@R16]; [@R26]). Abnormal expression of lncRNAs has been reported in various cancers ([@R25]; [@R14], [@R15]; [@R42]). HOX antisense intergenic RNA is highly expressed in breast cancer ([@R19]). The long noncoding RNA metastasis associated in lung adenocarcinoma transcript 1, which is highly expressed in non-small-cell lung cancer tissue, is related to patient survival ([@R37]). [@R14], [@R15] reported the aberrant expression of lncRNAs in OPLs compared with normal oral mucosa using serial analysis of gene expression (SAGE). However, the role of aberrant expression of lncRNAs in the molecular pathogenesis of OPLs remains largely unknown.

In this study, the GSE31021 dataset constructed by [@R14], [@R15] and deposited in Gene Ontology Ominibus (GEO) was selected. Analysis was carried out using a series of bioinformatics methods. First, we identified differentially expressed lncRNAs and genes (DEGs), and predicted the target genes of lncRNAs. Then, gene ontology (GO) function and pathway enrichment analyses \[Kyoto Encyclopedia of Genes and Genomes (KEGG)\] were carried out to determine the target genes of lncRNAs. The resulting findings can help better understand OPLs and the underlying molecular mechanisms in lncRNA perspective, providing potential targets for further studies on strategies of lncRNA-based early diagnostics as well as justification of intervention timing and measures.

Materials and methods
=====================

SAGE datasets
-------------

This study was approved by the institutional review board of Beijing Stomatological Hospital Capital Medical University. To identify differentially expressed lncRNAs in OPLs, the SAGE dataset GSE31021 was downloaded from GEO ([*https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31021*](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31021)); it includes tissue samples of 10 OPLs (four severe, four moderate, and two mild dysplasia cases) with 10 SAGE libraries generated from oral biopsies. The expression profiling of the normal oral mucosa tissue was determined from the GSE8127 dataset ([*https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE8127*](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE8127)), which comprises six samples with three SAGE libraries generated from oral epithelial cells obtained from tongue brushes and three others obtained from oral biopsies. The two datasets were generated by the GPL4 platform (SAGE:10:NlaIII:*Homo sapiens* including 265 577 tag sequence) from nine individual patients with no histological evidence of invasion. Sixteen SAGE libraries deposited under GSE31021 and GSE8127 were constructed by the same research group according to the MicroSAGE protocol ([*http://www.sagenet.org/protocol/index.htm*](http://www.sagenet.org/protocol/index.htm)). The total tags sequenced per library ranged from 126 000 to 191 700, averaging 160 000 SAGE tags, excluding linker and duplicate ditags.

Data preprocessing
------------------

According to the information available in NCI ([*ftp://ftp1.nci.nih.gov/pub/SAGE/HUMAN/*](ftp://ftp1.nci.nih.gov/pub/SAGE/HUMAN/)), tags specifically mapped to genes were screened out by commanding shell. On the basis of the lncRNA sequence information derived from GENCODE ([*ftp://ftp.sanger.ac.uk/pub/gencode/Gencode_human/release_18/gencode.v18.lncRNA_transcripts.fa.gz*](ftp://ftp.sanger.ac.uk/pub/gencode/Gencode_human/release_18/gencode.v18.lncRNA_transcripts.fa.gz)) ([@R22]), unmapped tags were aligned with lncRNA sequences and the corresponding lncRNAs were screened out. When multiple tags mapped to the same lncRNA, tags were collapsed by summing up the tag counts to estimate the expression value of the lncRNA. Predicted mRNAs and lncRNAs were annotated on the basis of data available in the National Center of Biotechnology Information database.

Screening of differentially expressed lncRNAs and DEGs
------------------------------------------------------

Tag names were converted into genes or lncRNAs during the annotation. The remaining missing values were imputed using the *k*-nearest-neighbor algorithm, with the default *k* value set at 10 ([@R23]). The expression levels of multiple tags corresponding to the same gene were averaged. The lncRNA expression matrices for the 16 samples were normalized using Robust Microarray Averaging. Differentially expressed lncRNAs and DEGs were screened with the LIMMA package in R ([@R40]). The false discovery rate was determined by the Benjamini--Hochberg (BH) method using Multtest package ([@R34]). False discovery rate less than 0.05 and \|log~2~(fold change)\|\>0.585 were selected as criteria for lncRNA and DEG screening. The heat map of DEGs was obtained using the gplots package in R to assess their distribution in different samples.

Prediction of target genes of differentially expressed lncRNAs
--------------------------------------------------------------

To decipher the role of lncRNAs in the molecular pathogenesis of OPLs, the lncRNA-gene coexpression network was assessed. Coexpression levels of lncRNAs and genes were used to predict potential target genes for lncRNAs. The Pearson correlation coefficients of lncRNAs and genes were calculated using R, and interactions with Pearson's correlation coefficient more than 0.95 and *P* value of less than 0.05 were selected to predict the target genes of lncRNAs.

Functional analysis of target genes regulated by lncRNAs
--------------------------------------------------------

The target genes of lncRNAs were subjected to GO and KEGG enrichment analyses using Database for Annotation, Visualization, and Integrated Discovery ([@R8]). The Enrichment Map Plugin in the Cytoscape was used to present enrichment results ([@R38]; [@R30]).

Results
=======

DEGs and differentially expressed lncRNAs
-----------------------------------------

A total of 265 577 tags were identified in the GPL4 platform, with 43 455 mapped to 16 233 genes. After aligning the unmapped tags to the lncRNA sequences, 1651 tags were mapped to 1409 lncRNAs.

The box plots of expression data were distributed at similar intervals and densities after normalization, indicating successful adjustment (Fig. [1](#F1){ref-type="fig"}). The normalized data were used for further analysis. A total of 674 DEGs and differentially expressed lncRNAs showing statistical significance (*P*\<0.05) were identified, including 648 downregulated DEGs, 16 upregulated DEGs, and 10 downregulated lncRNAs. No upregulated lncRNAs were found. The heat map (Fig. [2](#F2){ref-type="fig"}) shows a clear separation between OPLs and normal samples on the basis of the DEGs.

![Box plots of expression data before and after normalization using Robust Microarray Averaging.](cej-27-370-g001){#F1}

![Heat map of differentially expressed genes. In the figure, 'normal 1--3' represent biopsies from control samples and 'normal 4--6' are brushes from control samples; 'cases 4--5' represent mild dysplasia; 'cases 1, 2, 3, and 10' represent severe dysplasia, and 'cases 6--9' represent moderate dysplasia. Gene expression ratios were displayed by applying progressively brighter shades of black (downregulated) or white (upregulated) to normalized values that increasingly deviate from zero.](cej-27-370-g002){#F2}

Target genes of lncRNAs
-----------------------

Interactions with Pearson's correlation coefficient more than 0.95 and *P* value of less than 0.05 were determined. The coexpression network of lncRNAs and DEGs is presented in Fig. [3](#F3){ref-type="fig"}. Finally, we obtained 946 interactions for 10 downregulated lncRNAs and 531 downregulated DEGs. The top 10 interactions with the most target genes are listed in Fig. [4](#F4){ref-type="fig"}. *RP4-684O24*, *RP11-283I3*, and *RP11-350G8* coregulated 60 DEGs, and *LINC00665* and *MIR378D2* coregulated 55 DEGs (Table [1](#T1){ref-type="table"}). Excluding *NEAT1*, all the predicted lncRNAs coregulating target genes were new.

![Coexpression network of lncRNAs and differentially expressed genes (DEGs). Nodes represent downregulated DEGs. Angles represent the lncRNAs coregulating DEGs.](cej-27-370-g003){#F3}

![Interaction network of long noncoding RNAs (lncRNAs) and their target genes (top 10 interactions with the most target genes). Angles represent lncRNAs. Line thickness reflects the number of target genes.](cej-27-370-g004){#F4}

###### 

List of coregulated lncRNAs and the top 10 target genes
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GO function and KEGG enrichment findings
----------------------------------------

Cytoscape was used to construct the functional network. The target genes coregulated by *RP4-684O24*, *RP11-283I3*, and *RP11-350G8* mediated the immune response, protein complex biogenesis, and assembly. They were mainly located in the membrane and insoluble cellular fractions, and manifested mannosyl-oligosaccharide mannosidase, anion binding, and mannosidase activities (Table [2](#T2){ref-type="table"} and Fig. [5](#F5){ref-type="fig"}). The target genes coregulated by *LINC00665* and *MIR378D2* mainly regulated ubiquitin-dependent protein catabolism and response to calcium ion. They are mainly located in the cytosol, axons and dendrites, and synapses; they were predicted to bind protein C. They showed ubiquitin-protein ligase and small conjugating protein ligase activity, and participated in neurotrophin signaling, *Vibrio cholera* infection, and the insulin signaling pathway (Table [3](#T3){ref-type="table"} and Fig. [6](#F6){ref-type="fig"}).

###### 

Enrichment of target genes coregulated by *RP4-684O24*, *RP11-283I3*, and *RP11-350G8*
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![Gene ontology (GO) enrichment function modules of target genes coregulated by *RP4-684O24*, *RP11-283I3*, and *RP11-350G8*.](cej-27-370-g007){#F5}

###### 

Enrichment of target genes coregulated by *LINC00665* and *MIR378D2*
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![Gene ontology (GO) enrichment function modules of target genes coregulated by *LINC00665* and *MIR378D2*.](cej-27-370-g009){#F6}

Discussion
==========

The malignant transformation of OPLs may continue for a few years to decades. Such patients require long-term follow-up. Epithelial dysplasia is a key point in disease progression. Unfortunately, there are no reliable indicators of transforming OPLs for doctors to decide whether operation or other interventions should be carried out clinically. Meanwhile, carcinogenesis is a genetic process in which molecular changes occur earlier than histomorphological changes; indeed, carcinogenesis leads to changes in morphology and cellular behavior ([@R12]). Therefore, the most efficient way to screen for high-risk lesions and prevent malignant transformation is to identify genetic alterations that might typify epithelial dysplasia.

In this study, we carried out gene expression profile analysis using high-throughput bioinformatics methods to identify DEGs in OPLs compared with normal controls. The main advantages of using this approach are as follows: (a) the samples used in the SAGE dataset were derived from patients with OED, which indicates high-risk lesions. We focused on lncRNA expression in OPLs and filtered crucial lncRNAs that could be used as biomarkers for the accurate detection of high-risk lesions. As with histopathological guidance, a reliable and objective molecular marker can help doctors make the right clinical decisions on OPLs without biopsies, which is more acceptable to patients. (b) Unlike microarrays, SAGE is a sequence-based transcriptome profiling technique that provides the absolute abundance values of transcripts according to sequence tag counts, thus enabling the identification of DEGs and novel lncRNAs by direct comparison of gene expression levels across SAGE data without disparity among housekeeping genes. (c) It is a direct and simple method to identify DEGs and lncRNAs by calculation fold changes and *P*-values, especially for the preliminary screening of target genes using SAGE datasets; however, the results require further validation with large-scale clinical samples.

Here, a total of 1409 lncRNAs were identified; meanwhile, 664 DEGs (including 648 downregulated and 16 upregulated genes) and 10 differentially expressed lncRNAs (including 10 downregulated and no upregulated lncRNAs) were screened from the expression profiling of OPLs compared with the normal oral mucosa. These results corroborated the heat map. LncRNAs are recognized widely to play important roles in many biological processes and to show aberrant expression in tumors ([@R21]). Therefore, considerable research has focused on lncRNAs as potential biomarkers for various tumor types, including OSCC ([@R29]; [@R18]; [@R37]; [@R41]; [@R45]). Theoretically, the DEGs and lncRNAs identified can help clinicians differentiate the OPLs with dysplasia from those with low-risk malignant transformation. Nevertheless, this is far from clinical requirements and in-depth studies are warranted to translate potential biomarker candidates into clinically available diagnostic tools in the future.

The lncRNA *NEAT1* was most highly expressed in OPLs in previous SAGE analyses ([@R14], [@R15]). *NEAT1* plays an architectural role in the structure of paraspeckles ([@R5]) and is involved in cancer metastasis ([@R20]). *NEAT1* is overexpressed in lung cancer metastasis compared with matched primary tumors ([@R45]), hepatocellular carcinoma ([@R29]), and cervical cancer ([@R18]). *NEAT1* is highly expressed in saliva from patients with oral squamous cell carcinoma ([@R41]). Thus, *NEAT1* may play an important role in OPLs and represent a target gene for the diagnosis of OPL.

The target genes of *RP4-684O24*, *RP11-283I3*, and *RP11-350G8* were significantly enriched in immune response, protein complex biogenesis, and mannosyl-oligosaccharide mannosidase activity. The target genes of *LINC00665* and *MIR378D2* were significantly enriched in the ubiquitin-dependent protein catabolic process, ubiquitin-protein ligase activity, and the neurotrophin signaling pathway. Epidermal growth factor receptor was not only expressed in OPLs but also in lesions with mild dysplasia. MUC-1 and carcinoembryonic antigen were expressed in most patient samples. Further, autologous peripheral blood mononuclear leukocytes were stimulated to react with heterologous OPLs ([@R44]). In addition, circulating immune complex levels are increased in oral precancer and cancer patients ([@R27]). Mannosyl-oligosaccharide mannosidase plays a central role in the *N*-glycosylation pathway. Abnormal glycosylation is associated with progression, metastasis, and poor clinical outcomes in breast, colon, and skin cancers ([@R17]; [@R7]; [@R43]). Ubiquitin is an important signaling messenger in cell proliferation, cell cycle, and apoptosis ([@R24]). The ubiquitin ligase subunit S-phase kinase-associated protein shows oncogenic potential in breast epithelial cells and is highly expressed in breast carcinoma ([@R39]). Neurotrophins have been reported in cancers of the lung, bladder, and prostate ([@R31]; [@R35]; [@R36]). They use Trk tyrosine kinase receptors and the p75 neurotrophin receptor (p75NTR) to regulate the growth, development, survival, and repair of the nervous system. Neurotrophin nerve growth factor enhances cell survival by two distinct signaling pathways mediated by p75^NTR^ and nuclear factor-kB ([@R9]). Activated fibroblasts increase the levels of the brain-derived neurotrophic factor, which interacts with neurotrophin receptor B in oral tumor progression ([@R10]). However, the roles of mannosidase, ubiquitin, and neurotrophin in OPLs have never been reported. We conclude that they may be related to OPLs.

In brief, lncRNAs and DEGs mediate neurotrophin signaling in the pathogenesis of OPLs. In addition, mannosidase and ubiquitin may play important roles in OPLs. On the basis of the current understanding of molecular events, it may be possible to prevent the occurrence of OSCC by reversing the lesions by means of gain or loss of function of specific lncRNAs in epithelial dysplasia.

In this study, the two SAGE libraries used were constructed by the same research group using the same patient cohort, which provides a homogeneous and comparable basis for data analysis. Moreover, after normalization by tags per million value, the quality of raw data was confirmed from a consistent tag abundance distribution, a good match degree of every tag between the two samples, and the high quality of reads. However, methodological deficiencies of our approach still exist. Because of the complex diversity of gene networks, a huge volume of data, and sequencing errors, the strategy of screening DEGs according to fold change and linking them to biology activity of OPLs cannot provide a factual mechanism of how DEGs and lncRNAs are involved in OPLs. Clinical validation and functional experiments should be conducted to correct screening errors and investigate the regulatory mechanisms of coexpressed lncRNAs and DEGs.

Nevertheless, our findings indicated that some lncRNAs related to dysplasia were identified in OPLs using SAGE profiling analysis. The lncRNA *NEAT1* may play an important role in OPLs. However, most of the lncRNAs found are new, with unknown functions. Although the functions of target genes of lncRNAs were analyzed in GO and the KEGG pathway, additional studies are needed to confirm the findings and elucidate their actual mechanisms in the pathogenesis of OPLs, laying the foundation for developing OSCC prevention strategies on the basis of lncRNAs.
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